Medical Dosimetry
Volume 35, Issue 2 , Pages 115-121 , Summer 2010

Adjuvant Radiotherapy for Gastric Cancer: A Dosimetric Comparison of 3-Dimensional Conformal Radiotherapy, Tomotherapy® and Conventional Intensity Modulated Radiotherapy Treatment Plans

Presented at The Canadian Association of Radiation Oncology 22nd Annual Scientific Meeting, September 10–13, 2008, Montreal, Quebec, Canada.

  • Max Dahele, M.B., Ch.B.

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Matthew Skinner, M.Sc.

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Brenda Schultz, M.R.T.(T)

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Marlene Cardoso, M.R.T.(T)

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Chris Bell, M.R.T.(T)

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Yee C. Ung, M.D.

      Affiliations

    • Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Yee C. Ung, M.D., University of Toronto Department of Radiation Oncology and Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5

Received 11 January 2009 ,Accepted 10 March 2009.

References 

  1. Canadian Cancer Statistics 2007. Available at: http://www.cancer.ca/canada-wide/publications/publications%20on%20cancer%20statistics/∼/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/pdf%20not%20in%20publications%20section/2007%20Canadian%20Cancer%20Statistics%20%20PDF%20English_1816216925.ashx. Last accessed August 5, 2007
  2. Yeoh KG. How do we improve outcomes for gastric cancer?. J. Gastroenterol. Hepatol. 2007;22:970–972
  3. Foukakis T, Lundell L, Gubanski M, et al. Advances in the treatment of patients with gastric adenocarcinoma. Acta. Oncol. 2007;46:277–285
  4. Ng K, Meyerhardt JA, Fuchs CS. Adjuvant and neoadjuvant approaches in gastric cancer. Cancer. J. 2007;13:168–174
  5. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med. 2001;345:725–730
  6. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 2006;355:11–20
  7. Macdonald, J.S.; Smalley, S.; Benedetti, J.; et al. Postoperative combined radiation and chemotherapy improves disease free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup Study INT-0116 (SWOG 9008), Proceedings of the ASCO gastrointestinal cancers symposium 6; 2004.
  8. Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:283–293
  9. Della Biancia C, Hunt M, Furhang E, et al. Radiation treatment planning techniques for lymphoma of the stomach. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:745–751
  10. Leong T, Willis D, Joon DL, et al. 3D conformal radiotherapy for gastric cancer--results of a comparative planning study. Radiother. Oncol. 2005;74:301–306
  11. Wieland P, Dobler B, Mai S, et al. IMRT for postoperative treatment of gastric cancer: Covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:1236–1244
  12. Ringash J, Perkins G, Brierley J, et al. IMRT for adjuvant radiation in gastric cancer: A preferred plan?. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:732–738
  13. Milano MT, Garofalo MC, Chmura SJ, et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: Early clinical outcome and dosimetric comparison with conventional techniques. Br. J. Radiol. 2006;79:497–503
  14. Welsh JS, Patel RR, Ritter MA, et al. Helical tomotherapy: An innovative technology and approach to radiation therapy. Technol. Cancer. Res. Treat. 2002;1:311–316
  15. Vanderstraeten B, Reynaert N, Paelinck L, et al. Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med. Phys. 2006;33:3149–3158
  16. Sheng K, Molloy JA, Read PW. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:917–923
  17. Sheng K, Molloy JA, Larner JM, et al. A dosimetric comparison of non-coplanar IMRT versus helical tomotherapy for nasal cavity and paranasal sinus cancer. Radiother. Oncol. 2007;82:174–178
  18. Pezner RD, Liu A, Han C, et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother. Oncol. 2006;81:81–87
  19. Ten Haken RK, Lawrence TS. The clinical application of intensity-modulated radiation therapy. Semin. Radiat. Oncol. 2006;16:224–231
  20. Singh AK, Tierney RM, Low DA, et al. A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: Implications for radiation dose escalation in carcinoma of the pancreas. Radiat. Oncol. 2006;1:33
  21. Byrne T, Ramsey C, Mahan S, et al. The dosimetric impact of respiration motion on 3D, IMRT, and tomotherapy treatment delivery. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:2450
  22. Wysocka BA, Kassam Z, Lockwood G, et al. Assessment of intra and interfractional organ motion during adjuvant radiochemotherapy in gastric cancer. J. Clin. Oncol. 2007;25:15132
  23. Gierga DP, Chen GT, Kung JH, et al. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:1584–1595
  24. Zhang T, Lu W, Olivera GH, et al. Breathing-synchronized delivery: A potential four-dimensional tomotherapy treatment technique. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:1572–1578
  25. Duan J, Shen S, Fiveash JB, et al. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: A volumetric dose measurement study. Med. Phys. 2006;33:1380–1387
  26. Kanagaki B, Read PW, Molloy JA, et al. A motion phantom study on helical tomotherapy: The dosimetric impacts of delivery technique and motion. Phys. Med. Biol. 2007;52:243–255
  27. Thilmann C, Haring P, Thilmann L, et al. The influence of breathing motion on intensity modulated radiotherapy in the step-and-shoot technique: Phantom measurements for irradiation of superficial target volumes. Phys. Med. Biol. 2006;51:117–126
  28. Craft D, Suss P, Bortfeld T, et al. The tradeoff between treatment plan quality and required number of monitor units in intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:1596–1605
  29. Seco J, Sharp GC, Turcotte J, et al. Effects of organ motion on IMRT treatments with segments of few monitor units. Med. Phys. 2007;34:923–934
  30. Ehler ED, Nelms BE, Tome WA. On the dose to a moving target while employing different IMRT delivery mechanisms. Radiother. Oncol. 2007;83:49–56
  31. Jiang SB, Pope C, Al Jarrah KM, et al. An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys. Med. Biol. 2003;48:1773–1784
  32. Li XA, Qi XS, Pitterle M, et al. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:581–591
  33. Kassam Z, Lockwood G, O'Brien C, et al. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:713–719
  34. O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J. Clin. Oncol. 1997;15:246–250
  35. Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann. Oncol. 2005;16:549–557
  36. Kost S, Dorr W, Keinert K, et al. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int. J. Radiat. Biol. 2002;78:695–702
  37. Jansen EP, Saunders MP, Boot H, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:781–785
  38. Cassady JR. Clinical radiation nephropathy. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:1249–1256
  39. Wysocka B, Kassam Z, Lockwood G, et al. Late toxicity after adjuvant radiochemotherapy for gastric adenocarcinoma. J. Clin. Oncol. 2006;24:14042
  40. Macdonald JS. Role of post-operative chemoradiation in resected gastric cancer. J. Surg. Oncol. 2005;90:166–170
  41. Weiss E, Hess CF. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther. Onkol. 2003;179:21–30
  42. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104:1296–1303

PII: S0958-3947(09)00015-6

doi: 10.1016/j.meddos.2009.03.003

Medical Dosimetry
Volume 35, Issue 2 , Pages 115-121 , Summer 2010

Article Tools

* Image Usage & Resolution